The 10-day moving average for ABT crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
The Momentum Indicator moved above the 0 level on October 30, 2026. You may want to consider a long position or call options on ABT as a result. In 42 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 51%.
The Moving Average Convergence Divergence (MACD) for ABT just turned positive on October 09, 2026. Looking at past instances where ABT's MACD turned positive, the stock continued to rise in 34 of 54 cases over the following month. The odds of a continued upward trend are 63%.
ABT moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +5.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where ABT advanced for three days, in 170 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Aroon Indicator entered an Uptrend today. In 136 of 264 cases where ABT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.
The 10-day RSI Indicator for ABT moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 14 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 45%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 30 of 53 cases where ABT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 57%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
ABT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. ABT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.722) is normal, around the industry mean (4.142). P/E Ratio (35.461) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.853) is also within normal values, averaging (11.253). Dividend Yield (0.023) settles around the average of (0.011) among similar stocks. P/S Ratio (3.836) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 93 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
PODD moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend. In 27 of 34 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 79%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on PODD as a result. In 64 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for PODD just turned positive on October 06, 2026. Looking at past instances where PODD's MACD turned positive, the stock continued to rise in 31 of 45 cases over the following month. The odds of a continued upward trend are 69%.
The 10-day moving average for PODD crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.
Following a +7.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where PODD advanced for three days, in 208 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Aroon Indicator entered an Uptrend today. In 104 of 174 cases where PODD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 60%.
The 10-day RSI Indicator for PODD moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 15 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PODD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
PODD broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. PODD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.145) is normal, around the industry mean (4.142). P/E Ratio (27.334) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.047) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (3.294) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PODD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ABT | PODD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 31 | 43 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | 77 Overvalued | |
PROFIT vs RISK RATING 1..100 | 93 | 100 | |
SMR RATING 1..100 | 68 | 37 | |
PRICE GROWTH RATING 1..100 | 41 | 57 | |
P/E GROWTH RATING 1..100 | 4 | 96 | |
SEASONALITY SCORE 1..100 | 65 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PODD's Valuation (77) in the Medical Specialties industry is in the same range as ABT (78). This means that PODD’s stock grew similarly to ABT’s over the last 12 months.
ABT's Profit vs Risk Rating (93) in the Medical Specialties industry is in the same range as PODD (100). This means that ABT’s stock grew similarly to PODD’s over the last 12 months.
PODD's SMR Rating (37) in the Medical Specialties industry is in the same range as ABT (68). This means that PODD’s stock grew similarly to ABT’s over the last 12 months.
ABT's Price Growth Rating (41) in the Medical Specialties industry is in the same range as PODD (57). This means that ABT’s stock grew similarly to PODD’s over the last 12 months.
ABT's P/E Growth Rating (4) in the Medical Specialties industry is significantly better than the same rating for PODD (96). This means that ABT’s stock grew significantly faster than PODD’s over the last 12 months.
| ABT | PODD | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 45% | 1 day ago 63% |
| Stochastic ODDS (%) | 1 day ago 57% | 1 day ago 73% |
| Momentum ODDS (%) | 1 day ago 51% | 1 day ago 72% |
| MACD ODDS (%) | 1 day ago 63% | 5 days ago 69% |
| TrendWeek ODDS (%) | 1 day ago 54% | 1 day ago 75% |
| TrendMonth ODDS (%) | 1 day ago 51% | 1 day ago 69% |
| Advances ODDS (%) | 8 days ago 56% | 6 days ago 66% |
| Declines ODDS (%) | 4 days ago 56% | 4 days ago 71% |
| BollingerBands ODDS (%) | 1 day ago 52% | 1 day ago 68% |
| Aroon ODDS (%) | 1 day ago 52% | 1 day ago 60% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ABT’s FA Score shows that 1 FA rating(s) are green while PODD’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ABT’s TA Score shows that 6 TA indicator(s) are bullish while PODD’s TA Score has 7 bullish TA indicator(s).
ABT (@Medical/Nursing Services) experienced а +0.32% price change this week, while PODD (@Medical/Nursing Services) price change was -2.47% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.05%. For the same industry, the average monthly price growth was -4.41%, and the average quarterly price growth was -2.25%.
ABT is expected to report earnings on Jan 27, 2027.
PODD is expected to report earnings on Feb 25, 2027.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, ABT has been loosely correlated with MDT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then MDT could also see price increases.
A.I.dvisor indicates that over the last year, PODD has been loosely correlated with ISRG. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PODD jumps, then ISRG could also see price increases.
| Ticker / NAME | Correlation To PODD | 1D Price Change % | ||
|---|---|---|---|---|
| PODD | 100% | +2.25% | ||
| ISRG - PODD | 49% Loosely correlated | +1.71% | ||
| DXCM - PODD | 48% Loosely correlated | +2.09% | ||
| MDT - PODD | 44% Loosely correlated | +0.97% | ||
| SYK - PODD | 41% Loosely correlated | -0.04% | ||
| ABT - PODD | 40% Loosely correlated | +0.53% | ||
More | ||||